A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Waltz, M.D.
Children's Hospital Medical Center, Cincinnati
Principal Investigator - George Retsch-Bogart, M.D.
University of North Carolina, Chapel Hill
Principal Investigator - Jeffrey Wagener, M.D.
The Children's Hospital
Principal Investigator - Pamela Zeitlin, M.D., Ph.D.
Johns Hopkins University
Principal Investigator - Peter Hiatt, M.D.
Baylor College of Medicine
Principal Investigator - Richard Moss, M.D.
Stanford University/Lucille Packard Children's Health Services at Stanford
Principal Investigator - Robert Wilmott, M.D.
Children's Hospital & Medical Center
Principal Investigator - Ronald Gibson, M.D., Ph.D.
Children's Hospital Regional Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University/lucille Packard Children'S Health Services at Stanford
Palo Alto, California, United States
- the Children'S Hospital
Denver, Colorado, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Children'S Hospital
Boston, Massachusetts, United States
- University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- Baylor College of Medicine
Houston, Texas, United States
- Children'S Hospital and Regional Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2000
- Primary completion
- —
- Completion
- 28 Feb 2002
- Last update posted
- 2 Mar 2010
- Registered enrollment
- 98
- Registry id
- NCT00006280
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.